Organon & Co (OGN)

30.62
-0.51(-1.64%)
After Hours
30.70
+0.08(+0.26%)
- Real-time Data
  • Volume:
    2,278,293
  • Bid/Ask:
    30.55/31.36
  • Day's Range:
    30.13 - 31.06

OGN Overview

Prev. Close
31.13
Day's Range
30.13-31.06
Revenue
4.7B
Open
31.04
52 wk Range
27.37-38.75
EPS
-
Volume
2,278,293
Market Cap
7.76B
Dividend (Yield)
1.12
(3.60%)
Average Vol. (3m)
1,875,340
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
253,550,029
Next Earnings Date
Feb 24, 2022
What is your sentiment on Organon & Co?
or
Market is currently closed. Voting is open during market hours.

Organon & Co Company Profile

Employees
0

Organon & Co., a science-based pharmaceutical company, develops and delivers health solutions through a portfolio of prescription therapies within women’s health, biosimilars, and established brands. Its women’s health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company’s biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio in the United States, Canada, Australia, and Ukraine. It also has a portfolio of established brands in cardiovascular, respiratory, dermatology, and non-opioid pain management. The company sells its products primarily to drug wholesalers and retailers, hospitals, government agencies, and managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon & Co. operates independently of Merck & Co., Inc. as of June 2, 2021.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellSell
Technical IndicatorsStrong SellStrong BuyStrong SellStrong SellStrong Buy
SummaryStrong SellNeutralStrong SellStrong SellNeutral
  • Turning out to be a good move.
    0
    • Div day on 20th. Then what? Hold?
      0
      • dividend day is the 20th. Get it or wait...
        0
        • Buffet Effecf :D
          0
          • OGN even pays a decent dividend.
            0
            • so if you don't know, a fund wanted to buy some shares below the price of the market (below 29), now see that the shares goes down. Personally i will just hold myself to the sit and keep an eye on the data...
              0
              • This will be a good company just like Merck, just not as big, for now. Profit can be better than size and disproportionate.
                0
                • the best moment to buy is probably right now
                  0
                  • the price starts slowly to look like something
                    0
                    • P/E is 4. Now where do you get such pricing in the market
                      0
                      • snc lavalin
                        0
                      • more seriously, i am also a shareholder. while i agree that organon deserves a higher price, they are mostly producing OTC drugs (low added value) and i read that they are going to borrow money to develop new drugs (meaning no shares buy back). So a lower p/e than the industry is not absurd.
                        0
                      • which is why this is such low risk investment at this price. they will invest and see share price appreciation along the way, inti the future.
                        0
                    • why couldn't you wait that i have actually my shares, to make the price go down ? #sad
                      0
                      • Is people are sexists or because women's health should be free that the price is collapsing ?
                        0
                        • the same question but in correct English... 🙄
                          0
                        • Haha, neither. MRK is in the S&P. OGN is not. If you own S&P ETFs, Blackrock etc would also receive OGN. But since OGN is not in the S&P, they are forced to sell. Similar thing with MRK shareholders who do not like uncertainty.
                          0
                        • i couldn't sell the shares that i received from Merck. They are blocked...
                          0
                      • omg women medicine...
                        0
                        • This can only be a nice bonus. Will keep shares for a while and see how it goes. Free money.
                          5
                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.